Searched for
ZOETIS
Pfizer Q4 Results: Net profit jumps 85% to Rs 331 crPfizer Ltd has reported an 85 per cent jump in net profit at Rs 330.94 crore in the fourth quarter ended March 2025, boosted by a gain in e...- French bird flu vaccine campaign helps poultry output recover, producers sayFrance's 2023 bird flu vaccination campaign has successfully helped poultry production bounce back to pre-crisis levels. Despite concerns a...
- US animal health major Zoetis expands GCC in HyderabadZoetis, the world's largest producer of pet and livestock medicine, is expanding its global capability centre in Hyderabad. The centre will...
- Syngene Q2 Results: Net profit jumps 14% to Rs 117 croreNet profit before an exceptional item rose 20% YoY to 122 crore. The exceptional item pertains to transaction costs relating to the acquisi...
- Syngene International Q4 Results: Net profit jumps 21% to YoY Rs 179 croreHunt said the manufacturing services had a particularly strong year, led by the commercial-scale biologics manufacturing business, which ha...
- Syngene reports Rs 102 crore net profit in Q2FY23The company reported net profit of Rs 102 crore during Q2FY23, compared to Rs 67 crore during the corresponding quarter of the previous yea...
- Hot Stocks: Brokerages on Syngene, Home First Finance and Devyani InternationalBrokerage CLSA maintained a buy rating on Syngene International while Motilal Oswal initiated coverage on Home First Finance with a buy cal...
- Syngene to benefit from rupee depreciation, rising demand for research & manufacturing services: CEO Jonathan HuntSyngene has raised the revenue guidance for FY23 from mid-teens to high teens due to significant depreciation of rupee against the dollar a...
- Jonathan Hunt on growth triggers which led to upgrade of Syngene sales guidance“ Syngene has signed a 10-year strategic deal with Zoetis in animal health: It was a real piece of innovation from Zoetis and we are deligh...
- Sensex rises after 4-day hiatus amid gains in FMCG, auto stocks"Investors have turned their focus on upcoming Fed policy in the backdrop of heightened US inflation," said Vinod Nair of Geojit Financial ...
- Dogs or cats catching Covid is low but not impossible, so why don’t we have a vaccine for pets yet?Although the evidence so far suggests that the virus is not a major threat to pets, there is a lot left to learn.
- Aurobindo Pharma to buy US animal health firm Cronus for Rs 420 crHyderabad-based Cronus is engaged in development, manufacturing and sale of veterinary pharmaceutical products and has a large exposure in ...
- Nine great apes in San Diego become first non-human primates vaccinated for Covid-19Nine great apes at the San Diego Zoo - four orangutans and five bonobos - made veterinary history in recent weeks as the world's first non-...
- Buy Syngene International, target price Rs 635: ICICI DirectSyngene International Ltd., incorporated in the year 1993, is a Mid Cap company (having a market cap of Rs 22012.00 Crore) operating in Pha...
- Centre likely to cap veterinary drug pricesCentre is mulling to cap the prices of a new catalogue of veterinary drugs and vaccines in a bid to boost the Prime Minister's new initiati...
- 6 British agri-tech firms line up for trade show in ChandigarhThe UK is the ‘Guest Country’ in the 12th edition of Agro-Tech. The British delegation will join the British Pavilion at Agro-Tech show in ...
- Merial, Zoetis ink pact for dairy products in IndiaMerial, the animal health division of Sanofi, has inked a pact with Zoetis India to sell its medicines and vaccines for dairy cattle in Ind...
- Zydus Cadila to acquire select animal health brands from ZoetisZydus operates its veterinary business through Zydus Animal Health. The company did not disclose the financial details of the deal.
- Pfizer to buy back $10 b in stock in line with its repurchase strategyThis is the fourth major share repurchase programme for New York-based company in past two-and-a-half years.
- EC fines Ranbaxy, others for blocking cheaper drugsEC imposed a fine of 146 million euros on nine pharma companies, including Ranbaxy Laboratories, for delaying market entry of cheaper gener...
Load More
